RAC1 and cancer: However, modern DNA-sequencing tools that allow large-scale sequencing of entire cancer genomes has now dramatically changed the scene, and the first step to an altered view on RHO GTPases as oncogenes came from the identification of a recurrent somatic point mutations in RAC1 (RAC1/P29S) in a sun-exposed melanoma, in 2012 [5].